Hesperidin as a preventive resistance agent in MCF–7 breast cancer cells line resistance to doxorubicin

Hesperidin as a preventive resistance agent in MCF–7 breast cancer cells line resistance to doxorubicin

Objective: To evaluate of hesperidin to overcome resistance of doxorubicin in MCF-7 resistant doxorubicin cells (MCF-7/Dox) in cytotoxicity apoptosis and P-glycoprotein (Pgp) expression in combination with doxorubicin. Methods: The cytotoxic properties, 50% inhibition concentration (IC50) and its co...

Full description

Bibliographic Details
Main Authors:	Rifki Febriansah, Dewi P.P. Dyaningtyas, Sarmoko, Nunuk Aries Nurulita, Edy Meiyanto, Agung Endro Nugroho
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2014-03-01
Series:	Asian Pacific Journal of Tropical Biomedicine
Subjects:	Hesperidin Doxorubicin MCF-7/Dox cells line Apoptosis Pgp expression
Online Access:	http://www.sciencedirect.com/science/article/pii/S2221169115301970

Similar Items

Apigenin and Hesperidin Downregulate DNA Repair Genes in MCF-7 Breast Cancer Cells and Augment Doxorubicin Toxicity
by: Agnieszka Korga-Plewko, et al.
Published: (2020-09-01)

In vitro synergistic effect of hesperidin and doxorubicin downregulates epithelial-mesenchymal transition in highly metastatic breast cancer cells
by: Nur Dina Amalina, et al.
Published: (2023-03-01)

Identification of key lncRNAs in exosomes with doxorubicin resistance in the MCF7 cells
by: Jiangyang Wan, et al.
Published: (2023-08-01)

The role of hesperidin as a cardioprotective strategy against doxorubicin-induced cardiotoxicity: The antioxidant, anti-inflammatory, antiapoptotic, and cytoprotective potentials
by: Fawiziah K. Alharbi, et al.
Published: (2023-12-01)

The Cytotoxic and Antimigratory Activity of Brazilin-Doxorubicin on MCF-7/HER2 Cells
by: Riris Istighfari Jenie, et al.
Published: (2018-08-01)

Identification of co-regulated genes associated with doxorubicin resistance in the MCF-7/ADR cancer cell line
by: Ali Miri, et al.
Published: (2023-06-01)

Combinatorial Cytotoxic Effects of Damnacanthal and Doxorubicin against Human Breast Cancer MCF-7 Cells in Vitro
by: Muhammad Yusran Abdul Aziz, et al.
Published: (2016-09-01)

Investigating the therapeutic effect of doxorubicin and resveratrol on MCF7 breast cancer cells
by: Shima Zorati pour, et al.
Published: (2023-09-01)

Molecular mechanisms associated with the chemoprotective role of protocatechuic acid and its potential benefits in the amelioration of doxorubicin-induced cardiotoxicity: A review
by: Edozie S. Okpara, et al.
Published: (2022-01-01)

Magnetic nanoparticles sensitize MCF-7 breast cancer cells to doxorubicin-induced apoptosis
by: Aljarrah Khaled, et al.
Published: (2012-04-01)

The synergistic effect of doxorubicin and ethanolic extracts of Caesalpinia sappan L. wood and Ficus septica Burm. f. leaves on viability, cell cycle progression, and apoptosis induction of MCF7 cells
by: Sari Haryanti, et al.
Published: (2016-06-01)

Hesperidin Nanoformulation: A Potential Strategy for Reducing Doxorubicin-Induced Renal Damage via the Sirt-1/HIF1-α/VEGF/NF-κB Signaling Cascade
by: Fatemah A. Alherz, et al.
Published: (2024-08-01)

Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting
by: Jihoon Lee, et al.
Published: (2023-05-01)

Preparation and evaluation of poly(l-histidine) based pH-sensitive micelles for intracellular delivery of doxorubicin against MCF-7/ADR cells
by: Nan Jia, et al.
Published: (2017-09-01)

A Comparative Study of Hesperetin, Hesperidin and Hesperidin Glucoside: Antioxidant, Anti-Inflammatory, and Antibacterial Activities In Vitro
by: Sung-Sook Choi, et al.
Published: (2022-08-01)

Glucosyl hesperidin exhibits more potent anxiolytic activity than hesperidin accompanied by the attenuation of noradrenaline induction in a zebrafish model
by: Takumi Nishida, et al.
Published: (2023-08-01)

DOX-Vit D, a Novel Doxorubicin Delivery Approach, Inhibits Human Osteosarcoma Cell Proliferation by Inducing Apoptosis While Inhibiting Akt and mTOR Signaling Pathways
by: Zaid H. Maayah, et al.
Published: (2018-09-01)

Modulation of doxorubicin-induced expression of the multidrug resistance gene in breast cancer cells by diltiazem and protection against cardiotoxicity in experimental animals
by: Hamdan S. Al-malky, et al.
Published: (2019-07-01)

EFFECT OF THE C60 FULLERENE, DOXORUBICIN AND THEIR COMPLEX ON CANCER AND NORMAL CELLS OF BALB/c MICE
by: Prylutska S. V., et al.
Published: (2014-02-01)

Effect of recombinant human erythropoietin and doxorubicin in combination on the proliferation of MCF-7 and MDA-mb231 breast cancer cells
by: Radwan, Esam M., et al.
Published: (2016)

Allicin and L-carnitine as Preventive Agents Against Doxorubicin-induced Cardiac Damage in Rats
by: Ahmed Soliman, et al.
Published: (2024-08-01)

Effect of Alkaline Conditions on Forming an Effective G4.0 PAMAM Complex with Doxorubicin
by: Magdalena Szota, et al.
Published: (2023-03-01)

UHPLC-MS/MS Assay for Quantification of Legubicin, a Novel Doxorubicin-Based Legumain-Activated Prodrug, and Its Application to Pharmacokinetic and Tissue Distribution Studies
by: Liyuan Ma, et al.
Published: (2024-02-01)

Targeting mitochondrial dynamics proteins for the treatment of doxorubicin-induced cardiotoxicity
by: Rui Chen, et al.
Published: (2023-08-01)

Melatonin Restores Autophagic Flux by Activating the Sirt3/TFEB Signaling Pathway to Attenuate Doxorubicin-Induced Cardiomyopathy
by: Yanyan Ma, et al.
Published: (2023-09-01)

In Vitro Biological Activities of Hesperidin-Related Compounds with Different Solubility
by: Hyo-Jun Lee, et al.
Published: (2024-06-01)

Chitosan/Hesperidin Nanoparticles for Sufficient, Compatible, Antioxidant, and Antitumor Drug Delivery Systems
by: May Almukainzi, et al.
Published: (2024-07-01)

Doxorubicin Assisted by Microsecond Electroporation Promotes Irreparable Morphological Alternations in Sensitive and Resistant Human Breast Adenocarcinoma Cells
by: Nina Rembiałkowska, et al.
Published: (2020-04-01)

The Adaptation of MCF-7 Breast Cancer Spheroids to the Chemotherapeutic Doxorubicin: The Dynamic Role of Phase I Drug Metabolizing Enzymes
by: Daniel Crispim, et al.
Published: (2025-02-01)

Evaluation of anti-proliferative activity of simvastatin and atorvastatin on MCF7 cell line compared with doxorubicin using MTT test
by: Aiyat Hasan Yahya Al-khafaji, et al.
Published: (2018-12-01)

Overexpression of miR-506-3p reversed doxorubicin resistance in drug-resistant osteosarcoma cells
by: Xinru Wang, et al.
Published: (2024-02-01)

Hesperidin as a natural Radio-Protector
by: Zhila Ghorbani, et al.
Published: (2015-12-01)

Reversal of Multidrug Resistance by Apolipoprotein A1-Modified Doxorubicin Liposome for Breast Cancer Treatment
by: Duopeng An, et al.
Published: (2021-02-01)

Glutoxime, as an Inhibitor of Multiple Drug Resistance Phenotype Associated with Pgp Expression
by: T. A. Bogush, et al.
Published: (2020-05-01)

Inflammatory Reprogramming Mediates Changes in Three-Dimensional Strain Capacity and Cardiac Function in Beagle Dogs with Doxorubicin-Related Cardiomyopathy
by: Yifan Chen, et al.
Published: (2024-02-01)

Investigation of the Effects of Hesperidin on Bisphenol-A Induced Neurotoxicity in Rats
by: Burak Batuhan Laçin, et al.
Published: (2024-04-01)

Safety of glucosyl hesperidin as a Novel food pursuant to Regulation (EU) 2015/2283
by: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
Published: (2024-08-01)

Optical Properties of Doxorubicin Hydrochloride Load and Release on Silica Nanoparticle Platform
by: Trong Nghia Nguyen, et al.
Published: (2021-06-01)

Protective and therapeutic effects of hesperidin in an experimental colitis model
by: Serdal Öğüt, et al.
Published: (2024-11-01)

Doxorubicin-Loaded Iron Oxide Nanoparticles Induce Oxidative Stress and Cell Cycle Arrest in Breast Cancer Cells
by: Elisa Parcero Hernandes, et al.
Published: (2023-01-01)